Details of the Drug Formulations

General Information of Drug (ID: DMGL19D)

Drug Name
Enzalutamide Drug Info
Synonyms MDV3100; Enzalutamide (AR inhibitor)
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Approved [1]
Cross-matching ID
PubChem CID
15951529
ChEBI ID
CHEBI:68534
CAS Number
915087-33-1
TTD ID
D0QK5X
ACDINA ID
D01051

Full List of Drug Formulations Containing This Drug

Enzalutamide 40mg tablet
Company Formulation ID FDA Description
Astellas F24056 Hypromellose Acetate Succinate; Microcrystalline Cellulose; Colloidal Silicon Dioxide; Croscarmellose Sodium; Magnesium Stearate; Hypromellose; Talc; Polyethylene Glycol; Titanium Dioxide; Ferric Oxide
------------------------------------------------------------------------------------
Enzalutamide 80mg tablet
Company Formulation ID FDA Description
Astellas F24057 Hypromellose Acetate Succinate; Microcrystalline Cellulose; Colloidal Silicon Dioxide; Croscarmellose Sodium; Magnesium Stearate; Hypromellose; Talc; Polyethylene Glycol; Titanium Dioxide; Ferric Oxide
------------------------------------------------------------------------------------
Enzalutamide 40mg capsule
Company Formulation ID FDA Description
Astellas F23734 Caprylocaproyl Polyoxylglycerides; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Gelatin; Sorbitol Sorbitan Solution; Glycerin; Purified Water; Titanium Dioxide; Black Iron Oxide
------------------------------------------------------------------------------------

References

1 Nat Rev Drug Discov. 2013 Feb;12(2):87-90.